Therapeutic translation of GLP1 receptor agonists Therapeutic translation of GLP1 receptor agonists In 1992, John Eng isolated exendin--a small peptide encoded within the Heloderma lizards proglucagon gene
Semaglutide is the active ingredient in the following brand-name drugs: Ozempic, Wegovy, and Rybelsus
Diabetes Care Center, Jinnouchi Hospital, 6-2-3 Kuhonji, Chuo-ku, Kumamoto 862-0976, Japan Tel: +81-96-363-0011, Fax: +81-96-364-2654, E-mail: [email protected] Copyright 2025 Korean Endocrine Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
Semaglutide mimics the action of natural GLP-1
This creates a different variability structure than that of conventional oral formulations, in which absorption varies continuously